Diagnosing hypercalcemia is often challenging because a wide spectrum of diseases-such as malignancy, granulomatous disease, and primary hyperparathyroidism-should be considered. Sarcoidosis is a rare cause of hypercalcemia. The case of a 77-year-old male presenting with sarcoidosis-associated hypercalcemia whose serum 1,25(OH)2D level was normal is reported here. Despite a normal 1,25(OH) 2 D level and minimally enlarged hilar lymphadenopathy, the serum angiotensin-converting enzyme (ACE) level was increased. Mediastinoscopic biopsy of the right lower paratracheal lymph node revealed pathological findings compatible with sarcoidosis. Treatment with 30 mg/day oral prednisone was started. Currently, the patient is being treated with a tapered dose of oral prednisone and small doses of vitamin D and calcium. Despite its low incidence, sarcoidosis should be considered a cause of hypercalcemia. The important diagnostic factors are not only serum calcitriol levels but also serum ACE levels and pathological findings. (Korean J Med 2015;88:207-211) 
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INTRODUCTION
Sarcoidosis is an inflammatory disease of unknown cause that affects multiple organs and is characterized by the accumulation of non-caseating granulomas [1] . The organs most commonly affected are the lungs, skin, eyes, and extrathoracic lymph nodes, and the course is usually benign and self-limiting. However, while approximately two-thirds of patients with sarcoidosis -The Korean Journal of Medicine: Vol. 88, No. 2, 2015 --208 -generally have remission within a decade after diagnosis, some patients suffer from clinically significant organ damage [1] .
The prevalence of hypercalcemia in sarcoidosis varies from 2% to 63% [2] ; however, clinically significant hypercalcemia is infrequent, occurring in approximately 5% of all cases of sarcoidosis with hypercalcemia. Because long-standing hypercalcemia and hypercalciuria is followed by nephrolithiasis and renal insufficiency, adequate management is required. Increased activity of 1α-hydroxylase, which converts 25(OH)D to 1,25(OH)2D, within the granuloma is known to be the main mechanism behind the hypercalcemia in sarcoidosis [1] . Corticosteroid is used to treat sarcoidosis-associated hypercalcemia because it preferentially inhibits 1α-hydroxylase in macrophages without affecting the same enzyme in renal tubular cells [3] . Based on the pathophysiological relationship between serum 1,25(OH)2D and calcium level, these two variables are generally correlated strongly and positively. In exceptional cases, however, the serum 1,25(OH)2D level is normal despite hypercalcemia. This can hamper diagnosis, as has been reported [4] . Here, we present a case of sarcoidosis-associated hypercalcemia with normal 1,25(OH)2D that delayed diagnosis.
CASE REPORT
A 77-year-old male visited the outpatient department of Kyungpook National University Hospital (KNUH) for evaluation of his long-standing hypercalcemia. In 2012, he was diagnosed at his local hospital with chronic kidney disease plus hypercalcemia. As his hypercalcemia was not considered to be severe, conservative management such as hydration was performed and he was discharged without any further evaluation. Several months later, 20 days before his admission to KNUH, the patient was admitted to another hospital. Routine chemistry testing revealed hypercalcemia (serum calcium 12.7 mg/dL) that was unresponsive to hydration; indeed, it rose even further to 13.8 mg/dL while the patient was being hydrated. Intriguingly, the patient did not have any other symptoms or signs associated with hypercalcemia. In addition, non-enhanced chest and abdomen computed tomography (CT) did not detect any tumors in the scanned regions. Therefore, the patient was referred to KNUH for further evaluation of his hypercalcemia. Having previously been diagnosed with essential hypertension, he was taking telmisartan and amlodipine. He had also previously been prescribed with a proton pump inhibitor and theophylline to treat reflux esophagitis and chronic obstructive pulmonary disease, respectively. To our knowledge, he had not been prescribed medications that affect serum calcium levels.
On the day of admission to KNUH, physical examination revealed a blood pressure of 136/83 mmHg and a heart rate of 81/min. The patient's serum calcium and phosphorous levels were 13.9 mg/dL and 4.3 mg/dL, respectively; his 24-h urine calcium level was 963.60 mg/day (normal: 100-300); and his blood nitrogen urea and serum creatinine levels were 25 mg/dL and 3.08 mg/dL, respectively. Ultrasonography of the kidney did not detect nephrolithiasis. A QuantiFERON Ⓡ -TB Gold test showed that the patient was negative for tuberculosis. Since the serum parathyroid hormone (PTH) level (4.42 pg/mL) was low (normal: 8-60 pg/mL), the possibility of primary hyperparathyroidism was ruled out. As tumor metastasis to the bone was the biggest concern, the patient was assessed for the presence of malignancy; however, a Tc 99m whole-body bone scan showed no evidence of bone metastasis. Instead, it showed increased linear uptake at lumbar vertebrae 4 and 5, which was suggestive of a compression fracture at this site (Fig. 1) . Chest radiography did not detect any nodules or masses, but showed subtle infiltration in both lower lung fields (Fig. 2) . Urinary free kappa and lambda chains and M-spikes were negative and the albumin-to-globulin ratio remained normal; thus, multiple myeloma was excluded.
Next, a chest CT taken at the previous hospital was carefully reviewed. This revealed the presence of right hilar lymphadenopathy and right lower paratracheal lymphadenopathy, albeit with minimal enlargement (Fig. 3) . Importantly, there were subpleural reticular densities in both lower lobes, which were suggestive of usual interstitial pneumonia (UIP) (Fig. 4) . It was difficult to interpret the lymphadenopathy because such mild mediastinal lymphadenopathy can be accompanied by not only pulmonary sarcoidosis but also interstitial lung diseases such as UIP. Moreover, the serum 1,25(OH)2D level (32.64 pg/mL) was The relationship between vitamin D and calcium levels in sarcoidosis was first revealed by a study performed more than 30 years ago, which showed that in sarcoidosis plasma 1,25(OH)2D
level correlates positively with serum calcium level, regardless of whether it is high or it resolves spontaneously or after treatment with prednisone [5] . The hypercalcemia in sarcoidosis, as well as in other granulomatous diseases such as tuberculosis, is due to the increased production of 1,25(OH)2D by pulmonary alveolar macrophages [6] . This elevation in turn depends on increased 1α-hydroxylase messenger ribonucleic acids (mRNA) expression in these macrophages [6] . Physiologically, the renal expression of 1α-hydroxylase is downregulated by 1,25(OH)2D but this negative feedback loop does not influence the expression of 1α-hydroxylase by sarcoid macrophages [7] . This causes the hypercalcemia seen in sarcoidosis.
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